Inventor

WESSON KIERON E

US25 patents

⚠️ This page may combine multiple inventors who share the name “WESSON KIERON E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WESSON KIERON E

EDISON PHARMACEUTICALS INC

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

2-substituted-p-quinone derivatives for treatment of oxidative stress diseases

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

BIOELECTRON TECH CORP

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

PTC THERAPEUTICS INC

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

Process for the production of alpha-tocotrienol and derivatives

4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

HINMAN ANDREW W

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

2-substituted-p-quinone derivatives for treatment of oxidative stress diseases

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

WESSON KIERON E

Process for the production of alpha-tocotrienol and derivatives

Process for the production of alpha-tocotrienol and derivatives

KOLESNIKOV ALEKSANDR

2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors

2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

JANKOWSKI ORION D

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

PHARMACYCLICS INC

2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

MILLER GUY M

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

PHARMACYCLICS LLC

2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors